354 related articles for article (PubMed ID: 20448203)
21. A monofunctional platinum(II)-based anticancer agent from a salicylanilide derivative: Synthesis, antiproliferative activity, and transcription inhibition.
Wang B; Wang Z; Ai F; Tang WK; Zhu G
J Inorg Biochem; 2015 Jan; 142():118-25. PubMed ID: 25450026
[TBL] [Abstract][Full Text] [Related]
22. Rationalization of the Superior Anticancer Activity of Phenanthriplatin: An In-Depth Computational Exploration.
Dabbish E; Russo N; Sicilia E
Chemistry; 2020 Jan; 26(1):259-268. PubMed ID: 31614021
[TBL] [Abstract][Full Text] [Related]
23. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V
Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593
[TBL] [Abstract][Full Text] [Related]
24. Translesion DNA synthesis across double-base lesions derived from cross-links of an antitumor trinuclear platinum compound: primer extension, conformational and thermodynamic studies.
Novakova O; Farrell NP; Brabec V
Metallomics; 2018 Jan; 10(1):132-144. PubMed ID: 29242879
[TBL] [Abstract][Full Text] [Related]
25. Specific DNA structural attributes modulate platinum anticancer drug site selection and cross-link generation.
Wu B; Davey GE; Nazarov AA; Dyson PJ; Davey CA
Nucleic Acids Res; 2011 Oct; 39(18):8200-12. PubMed ID: 21724603
[TBL] [Abstract][Full Text] [Related]
26. Transcription inhibition by platinum-DNA cross-links in live mammalian cells.
Ang WH; Myint M; Lippard SJ
J Am Chem Soc; 2010 Jun; 132(21):7429-35. PubMed ID: 20443565
[TBL] [Abstract][Full Text] [Related]
27. Recognition of platinum-DNA damage by poly(ADP-ribose) polymerase-1.
Zhu G; Chang P; Lippard SJ
Biochemistry; 2010 Jul; 49(29):6177-83. PubMed ID: 20550106
[TBL] [Abstract][Full Text] [Related]
28. Molecular interaction of DNA with bisplatinum(II) complexes having bis(vicinal 1,2-diamines) as ligand.
Büning H; Altman J; Beck W; Zorbas H
Biochemistry; 1997 Sep; 36(38):11408-18. PubMed ID: 9298960
[TBL] [Abstract][Full Text] [Related]
29. Rearrangement of interstrand cross-links into intrastrand cross-links in cis-diamminedichloroplatinum(II)-modified DNA.
Pérez C; Leng M; Malinge JM
Nucleic Acids Res; 1997 Feb; 25(4):896-903. PubMed ID: 9016644
[TBL] [Abstract][Full Text] [Related]
30. Kinetic analysis of the stepwise formation of a long-range DNA interstrand cross-link by a dinuclear platinum antitumor complex: evidence for aquated intermediates and formation of both kinetically and thermodynamically controlled conformers.
Cox JW; Berners-Price SJ; Davies MS; Qu Y; Farrell N
J Am Chem Soc; 2001 Feb; 123(7):1316-26. PubMed ID: 11456703
[TBL] [Abstract][Full Text] [Related]
31. The influence of the ethane-1,2-diamine ligand on the activity of a monofunctional platinum complex.
Graziotto ME; Akerfeldt MC; Gunn AP; Yang K; Somerville MV; Coleman NV; Roberts BR; Hambley TW; New EJ
J Inorg Biochem; 2017 Dec; 177():328-334. PubMed ID: 28789807
[TBL] [Abstract][Full Text] [Related]
32. Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies.
Kaspárková J; Mellish KJ; Qu Y; Brabec V; Farrell N
Biochemistry; 1996 Dec; 35(51):16705-13. PubMed ID: 8988007
[TBL] [Abstract][Full Text] [Related]
33. Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum(II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum(II).
Xu D; Min Y; Cheng Q; Shi H; Wei K; Arnesano F; Natile G; Liu Y
J Inorg Biochem; 2013 Dec; 129():15-22. PubMed ID: 24008133
[TBL] [Abstract][Full Text] [Related]
34. Cooperative effects in long-range 1,4 DNA-DNA interstrand cross-links formed by polynuclear platinum complexes: an unexpected syn orientation of adenine bases outside the binding sites.
Qu Y; Scarsdale NJ; Tran MC; Farrell NP
J Biol Inorg Chem; 2003 Jan; 8(1-2):19-28. PubMed ID: 12459895
[TBL] [Abstract][Full Text] [Related]
35. A novel DNA structure induced by the anticancer bisplatinum compound crosslinked to a GpC site in DNA.
Yang D; van Boom SS; Reedijk J; van Boom JH; Farrell N; Wang AH
Nat Struct Biol; 1995 Jul; 2(7):577-8. PubMed ID: 7664126
[TBL] [Abstract][Full Text] [Related]
36. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
Brabec V; Vrána O; Nováková O; Kleinwächter V; Intini FP; Coluccia M; Natile G
Nucleic Acids Res; 1996 Jan; 24(2):336-41. PubMed ID: 8628659
[TBL] [Abstract][Full Text] [Related]
37. Biophysical analysis of natural, double-helical DNA modified by a dinuclear platinum(II) organometallic compound in a cell-free medium.
Marini V; Kasparkova J; Novakova O; Monsú Scolaro L; Romeo R; Brabec V
J Biol Inorg Chem; 2002 Sep; 7(7-8):725-34. PubMed ID: 12203009
[TBL] [Abstract][Full Text] [Related]
38. Effect of geometric isomerism in dinuclear platinum antitumor complexes on DNA interstrand cross-linking.
Kaspárková J; Nováková O; Vrána O; Farrell N; Brabec V
Biochemistry; 1999 Aug; 38(34):10997-1005. PubMed ID: 10460154
[TBL] [Abstract][Full Text] [Related]
39. The effect of geometric isomerism on the anticancer activity of the monofunctional platinum complex trans-[Pt(NH
Zhou W; Almeqdadi M; Xifaras ME; Riddell IA; Yilmaz ÖH; Lippard SJ
Chem Commun (Camb); 2018 Mar; 54(22):2788-2791. PubMed ID: 29484327
[TBL] [Abstract][Full Text] [Related]
40. Inversion of the cis geometry requirement for cytotoxicity in structurally novel platinum(II) complexes containing the bidentate N,O-donor pyridin-2-yl-acetate.
Bierbach U; Sabat M; Farrell N
Inorg Chem; 2000 May; 39(9):1882-90. PubMed ID: 11428108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
